Antiasthmatic prescriptions in children with and without congenital anomalies: a population-based study.

ABSTRACT:

Objectives

To explore the risk of being prescribed/dispensed medications for respiratory symptoms and breathing difficulties in children with and without congenital anomalies.

Design

A EUROlinkCAT population-based data linkage cohort study. Data on children with and without congenital anomalies were linked to prescription databases to identify children who did/did not receive antiasthmatic prescriptions. Data were analysed by age, European region, class of antiasthmatic, anomaly, sex, gestational age and birth cohort.

Setting

Children born 2000-2014 in six regions within five European countries.

Participants

60 662 children with congenital anomalies and 1 722 912 reference children up to age 10 years.

Primary outcome measure

Relative risks (RR) of >1 ant

SUBMITTER: Divin N 

PROVIDER: S-EPMC10583066 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature